About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

7.015 -0.045 (-0.64%)

Streaming Delayed Price Updated: 10:26 AM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Earnings Preview For Organon ↗

February 15, 2023

Via Benzinga

Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023

February 06, 2023

From Organon & Co.

Via Business Wire

AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff ↗

January 31, 2023

Amgen launched its biosimilar knockoff on Tuesday at a steep discount.

Via Investor's Business Daily

'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock ↗

January 26, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy.

Via Benzinga

Organon Stock Scores Market Leadership With Jump To 83 RS Rating ↗

January 17, 2023

Organon sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

Organon Reports Better Than Expected Q3 Earnings ↗

November 03, 2022

Via Benzinga

Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy

January 05, 2023

From Organon & Co.

Via Business Wire

Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference

December 15, 2022

From Organon & Co.

Via Business Wire

Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary

December 12, 2022

From Organon & Co.

Via Business Wire

3 Dow Stocks to Take Seriously in 2023 ↗

November 29, 2022

The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.

Via InvestorPlace

'FTX Users May Seek DeFi Alternatives,' Interview With Origin Protocol's Andra Nicolau ↗

November 28, 2022

In a risk-off environment where cryptocurrency has plummeted to a fraction of its previous valuation, it’s no secret raising capital in 2022 has become a challenge for startups and industry behemoths...

Via Benzinga

Organon To Present at the Piper Sandler 34th Annual Healthcare Conference

November 15, 2022

From Organon & Co.

Via Business Wire

10 Spin-Off Stocks That Pay Dividends ↗

November 07, 2022

10 spin-offs from recent years that now pay dividends after being separated from their parent companies.

Via Talk Markets

Recap: Organon Q3 Earnings ↗

November 03, 2022

Organon (NYSE:OGN) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Organon beat estimated earnings by...

Via Benzinga

Organon Reports Results for the Third Quarter Ended September 30, 2022

November 03, 2022

From Organon & Co.

Via Business Wire

Looking Into Organon's Recent Short Interest ↗

November 02, 2022

Organon's (NYSE:OGN) short percent of float has fallen 4.48% since its last report. The company recently reported that it has 5.78 million shares sold short, which is 2.56% of all regular shares that...

Via Benzinga

Origin Protocol Building DeFi & NFTs In The Bear: Interview With Co-Founder Joshua Fraser ↗

November 01, 2022

Blockchain startups raised an aggregate of billions of dollars through the bull market, but it’s no secret those days are at least temporarily halted. For most DeFi protocols and almost every NFT...

Via Benzinga

Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022

October 20, 2022

From Organon & Co.

Via Business Wire

Beat the Dow Jones With This Unstoppable Dividend Stock ↗

October 19, 2022

This pharmaceutical stock combines strong financials with an above-average dividend.

Via The Motley Fool

Roofstock onChain Sells 1st Real Estate Property On Ethereum, Powered by Origin Protocol NFTs and Teller DeFi ↗

October 18, 2022

Leading real estate investment platform Roofstock announced its 1st property sale via Ethereum’s blockchain, enabled by Roofstock onChain (ROC), its web3 subsidiary. Roofstock onChain is a real estate...

Via Benzinga

Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation' ↗

October 18, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗

October 14, 2022

Upgrades

Via Benzinga

Netflix To Gain Around 8%? Plus This Analyst Slashes PT On Five9 By About 50% ↗

October 14, 2022

UBS boosted Netflix, Inc. (NASDAQ: NFLX) price target from $198 to $250. Netflix shares rose 5.3% to close at $232.51 on Thursday.

Via Benzinga

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

No Need To Call A Broker: Real Estate NFTs Let Homeowners Cut Out The Middleman Via Roofstock and Origin Protocol ↗

October 06, 2022

The $11 trillion real estate market remains a much talked about industry for streamlining access, reducing transaction friction, and democratizing ownership. Real estate technology company Roofstock...

Via Benzinga

How Is The Market Feeling About Organon? ↗

October 06, 2022

Organon's (NYSE:OGN) short percent of float has risen 11.91% since its last report. The company recently reported that it has 5.94 million shares sold short, which is 2.63% of all regular shares that...

Via Benzinga

After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff ↗

September 13, 2022

Via Benzinga

This Analyst Predicts $396 For Eli Lilly, Plus Raymond James Slashes PT On This Stock By Over 73% ↗

September 06, 2022

Raymond James cut the price target for PolyPid Ltd. (NASDAQ: PYPD) from $15 to $4. PolyPid shares fell 7.7% to $1.32 in pre-market trading.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

September 07, 2022

On Wednesday, 297 companies achieved new lows for the year.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 ↗

September 06, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Organon & Co. Common Stock (NY:OGN)

All News about Organon & Co. Common Stock

Sections

Services

Contact Information

Follow Us